Advertisement

Erkrankungen der Atmungsorgane

  • Werner Seeger
  • Joachim Lorenz
  • J. Christian Virchow
  • Adrian Gillissen
  • Stefan Zielen
  • Tobias Welte
  • Claus Vogelmeier
  • Thomas O. F. Wagner
  • Joachim Müller-Quernheim
  • Bettina Temmesfeld-Wollbrück
  • Norbert Suttorp
  • Hans-Dieter Walmrath
  • Friedrich Grimminger
  • H. Ardeschir Ghofrani
  • Frank Rose
  • Friedrich Grimminger
  • Dietmar Schranz
  • Michael Thomas
  • Rudolf M. Huber
  • Hubert Wirtz
  • Michael Schmidt
  • Jörg Hermann Peter
  • Dennis Nowak

Zusammenfassung

Eine akute Rhinitis ist meist Folge einer Tröpfcheninfektion durch respiratorische Viren (s. folgende Übersicht). Durch akute viral bedingte zytopathische Schleimhautveränderungen wird der Boden für Abflussbehinderungen der Nasennebenhöhlen und für eine bakterielle Infektion bereitet. Bei einer bakteriellen Superinfektion spielen Streptococcus pneumoniae (Pneumokokken) und andere typische Pathogene der Atemwege die Hauptrolle. Eine Sinusitis, die aufgrund der anatomischen Verhältnisse bei Kindern in bis zu 5% bei akuter Rhinitis auftritt, folgt auf die entzündliche Blockade des Sinusostiums. Auch sie ist überwiegend primär viral bedingt. Bakterielle Superinfektionen folgen gelegentlich. Anatomische Varianten (Septumdeviation, Nasenmuschelhyperplasie, Conchae bullosae, Adenoide) wirken dabei begünstigend. Bei Sinusitis maxillaris muss eine dentogene Genese bedacht werden, die Infektion ist in diesem Fall bakterieller Natur.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Balfour HH (1999) Antiviral Drugs. New Engl J Med 340: 1255–1268PubMedGoogle Scholar
  2. Betts RF (1995) Influenza virus. In: Mandell GL, Bennett JE, Do-lin R (eds) Principle and practice of infectious diseases. Chur¬chill Livingstone, New York, pp 1546–1567Google Scholar
  3. Boldy DA, Skidmore SJ, Ayres JG (1990) Acute bronchitis in the community: clinical features, infective factors, changes in pul¬monary function and bronchial reactivity to histamine. Re¬spir Med 84: 377–385Google Scholar
  4. Giezen WP (1982) Serious morbidity and mortality associated with influenza epidemics. Epidemiologic Reviews 4: 25–44Google Scholar
  5. Hayden FG, Osterhaus ADME, Treanor JJ, Fleming DM, GG 167 Influenza Study Group (1997)Google Scholar
  6. Efficacy and safety of the neu¬raminidase inhibitor zanamivir in the treatment of influenza virus infections. N Engl J Med 337:874–880Google Scholar
  7. Huchon G, Woodhead M (1998) Management of adult communi¬ty-acquired lower respiratory tract infections. Eur Respir Rev 8: 391–426Google Scholar
  8. Lorenz J (1998) Checkliste Pneumologie. Thieme, Stuttgart Lorenz J (2000) Tracheobronchitis und Influenza. In: Lorenz J (Hrsg) Atemwegsinfektionen in Klinik und Praxis. Unimed Verlag, Bremen, S 21–33Google Scholar
  9. Luckhaupt H, Borkowki G (2000) Obere Atemwegsinfektionen. In: Lorenz J (Hrsg) Atemwegsinfektionen in Klinik und Pra¬xis. Unimed Verlag, Bremen, S 11–20Google Scholar
  10. Vogel F, Worth H, Adam D et al. (1999) Rationale Therapie bak¬terieller Atemwegsinfektionen. Empfehlungen einer Experten¬gruppe der Paul-Ehrlich Gesellschaft für Chemotherapie und der Deutschen Atemwegsliga. Chemotherapie J 9: 3–23Google Scholar
  11. American Thoracic Society (1995) Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 152: 577 - S120Google Scholar
  12. Anthonisen NR, Connett JE, Kiley JP et al. (1994) Effects of smo¬king intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung He¬ath Study. JAMA 272: 1539–1541Google Scholar
  13. Anthonisen NR, Manfreda J, Warren CPW (1987) Antibiotic the¬rapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 106: 196–204PubMedGoogle Scholar
  14. Barnes P, Godfrey S (1997) Chronic obstructive pulmonary disea¬se. Martin Dunitz, LondonGoogle Scholar
  15. Barnes PJ (2000) Inhaled corticosteroids are not beneficial in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 161: 342–344PubMedGoogle Scholar
  16. British Thoracic Society (1997) Guidelines for the management of chronic obstructive pulmonary disease. Thorax 52: 51 - S28Google Scholar
  17. Calverley PMA (2000) Inhaled corticosteroids are beneficial in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 161: 341–344PubMedGoogle Scholar
  18. Canadian Thoracic Society Workshop Group (1992) Guidelines for the assessment and management of chronic obstructive pulmonary disease. Can Med Assoc J 147: 420–428Google Scholar
  19. Davies L, Angus RM, Calverley PMA (1999) Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial. Lancet 354: 456–460PubMedGoogle Scholar
  20. Demeester J, Smits JMA, Persijn GG, Haverich A (1999) Lung transplant waiting list: differential outcome of type of end-stage lung disease, one year after registration. J Heart Lung Transplant 18: 563–571Google Scholar
  21. Deutsche Gesellschaft für Pneumologie (1993) Empfehlungen zur Sauerstoff-Langzeit-Therapie bei schwerer chronischer Hyo¬xämie. Pneumologie 47: 2–4Google Scholar
  22. Fabbri LM, Caramori G, Beghe B, Papi A, Ciaccia A (1998) Chro¬nic obstructive pulmonary disease international guidelines. Curr Opin Pulm Med 4: 76–84PubMedGoogle Scholar
  23. Fletcher C, Peto R (1977) The natural history of chronic airway obstruction. Br Med J 1: 1645–1648Google Scholar
  24. Gehring S, Rabenau H, Schneider W, Zielen S (1996) Adenovirus¬infektionen als Ursache schwerer pulmonaler Erkrankungen im Kindesalter. Pädiatr Grenzgeb 34: 325–330Google Scholar
  25. Gillissen A, Buhl R, Kardos P et al. (2000) Inhalierbare Kortikos¬teroide in der Langzeittherapie der COPD. Stellungnahme ei¬nes Expertengremiums. Pneumologie 54: 256–262Google Scholar
  26. Gillissen A, Tasci S, Ewig S, Schäfer H, Zielen S (2001) Sinn und Unsinn von Antitussiva. Internist 42: 134–142PubMedGoogle Scholar
  27. Irwing RS, Boulet L-P, Cloutier MM et al. (1998) Managing cough as a defense mechanism and as a symptom. A consensus panel report of the American Chest Physicians. Chest 114: 133s - 181sGoogle Scholar
  28. Jorenby DE, Leischow SJ, Niedes MA et al. (1999) A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med 340: 685–691Google Scholar
  29. Kardos P, Gebhardt T, Decot E (1995) Chronisch persistierender Husten (CPH): Therapie. Pneumologie 49: 47–54Google Scholar
  30. Keenan SP, Brake D (1998) An evidence-based approach to no¬ninvasive ventilation in acute respiratory failure. Crit Care Clin 14: 359–372Google Scholar
  31. Medical Research Council Working Party (1981) Long term do¬miciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Lancet 1: 681–686Google Scholar
  32. Niewoehner DE, Erbland ML, Deupree RH et al. (1999) Effect of systemic glucocorticoids on exacerbations of chronic ob¬structive pulmonary disease. N Engl J Med 340: 1941–1947Google Scholar
  33. Nocturnal Oxygen Therapy Trial Group (1980) Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease. Ann Intern Med 93: 391–398Google Scholar
  34. Pauwels RA, Lofdahl C-G, Laitinen LA et al. (1999) Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smo¬king. N Engl J Med 340: 1948–1953PubMedGoogle Scholar
  35. Peter G, Lepow M, McCracken GHE (1991) Ribavirin therapy of respiratory syncytial virus. Report of the committee of in¬fectious diseases. Am Acad Pediatr 22: 581–587Google Scholar
  36. Petro W, Wettengel R, Worth H (1995) Empfehlungen zum struk¬turierten Patiententraining bei obstruktiven Atemwegserkran¬kungen. Pneumologie 49: 455–460Google Scholar
  37. Petty TL, Weinmann GG (1997) Building a national strategy for the prevention and management of and research in chronic obstructive pulmonary disease. JAMA 277: 246–253PubMedGoogle Scholar
  38. Schulz C, Riedel M, Gillissen A, Emslander HP (1998) Präopera¬tive Identifizierung des pulmonalen Risikopatienten vor Lun¬genresektion. Atemw Lungenkrkh 24: 205–214Google Scholar
  39. Tarpy SP, Celli BR (1995) Long-term oxygen therapy. N Engl J Med 333: 710–714PubMedGoogle Scholar
  40. Vestbo J, Sorensen T, Langer P, Brix A, Torre P, Viskum K (1999) Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised con¬trolled trial. Lancet 355: 1819–1823Google Scholar
  41. Wettengel R, Berdel D, Cegla U et al. (1994) Empfehlungen der Deutschen Atemwegsliga zum Asthma Management bei Er¬wachsenen und bei Kindern. Med Klinik 89: 57–67Google Scholar
  42. Wettengel R, Böhning W, Cegla U et al. (1995) Empfehlungen der Deutschen Atemwegsliga zur Behandlung von Patienten mit chronisch obstruktiver Bronchitis und Lungenemphysem. Med Klinik 90: 3–7Google Scholar
  43. Witt C, Schmidt W (2000) Risikofaktoren der COPD. In: Gillissen A (Hrsg) Die chronisch obstruktive Lungenerkrankung. Uni¬Med Verlag, Bremen, S 32–43Google Scholar
  44. World Health Organization (1961) WHO report of an expert com¬mittee: Definition and diagnosis of pulmonary disease with special reference to chronic bronchitis and emphysema. WHO Techn Rep Ser 213: 14–19Google Scholar
  45. Worth H, Adam D, Handrick W et al. (1997) Prophylaxe und The rapie von bronchiale Infektionen. Med Klinik 12: 699–704Google Scholar
  46. Angrill J, Agusti C, De Celis R et al. (2001) Bronchial inflamma¬tion and colonization in patients with clinically stable bron¬chiectasis. Am J Respir Crit Care Med 164: 1628–1632PubMedGoogle Scholar
  47. Barker AF, Couch L, Fiel SB et al. (2000) Tobramycin solution for inhalation reduces sputum Pseudomonas aeruginosa density in bronchiectasis. Am J Respir Crit Care Med 162: 481–485PubMedGoogle Scholar
  48. Barker AF (2002) Bronchiectasis. N Engl J Med 346: 1383–1393Google Scholar
  49. DÚrzo AD, De Salvo MC, Ramirez-Rivera A, Almeida J, Sichleti¬dis L, Rapatz G, Kottakis J (2001) In patients with COPD, tre¬atment with a combination of formoterol and ipratropium is more effective than a combination of salbutamol and ipratro¬pium: a 3-week, randomized, double-blind, within-patient, multicenter study. Chest 119: 1347–1356Google Scholar
  50. Grenier PA, Beigelman-Aubry C, Fetita C, Preteux F, Brauner MW, Lenoir S (2002) New frontiers in CT imaging of airway disea¬se. Eur Radiol. 12: 1022–1044PubMedGoogle Scholar
  51. Jones A, Rowe BH (2000) Bronchopulmonary hygiene physical therapy in bronchiectasis and chronic obstructive pulmonary disease: a systematic review. Heart Lung 29: 125–135PubMedGoogle Scholar
  52. Keistinen T, Saynajakangas O, Tuuponen T, Kivela SL (1997) Bronchiectasis: an orphan disease with a poorly-understood prognosis. Eur Respir J 10: 2784–2787PubMedGoogle Scholar
  53. Kutlay H, Cangir AK, Enon S et al. (2002) Surgical treatment in bronchiectasis: analysis of 166 patients. Eur J Cardiothorac Surg 21: 634–637PubMedGoogle Scholar
  54. Mal H, Rullon I, Mellot F, Brugiere O, Sleiman C, Menu Y, Four¬nier M (1999) Immediate and long-term results of bronchial artery embolization for life-threatening hemoptysis. Chest 115: 996–1001Google Scholar
  55. Mysliwiec V, Pina JS (1999) Bronchiectasis: the „other“ obstructi¬ve lung disease. Postgrad Med 106:123–126, 128–131Google Scholar
  56. O’Donell AE, Barker AF, Ilowite JS, Fick RB (1998) Treatment of idiopathic bronchiectasis with aerolised recombinant human rhDNase I. Chest 113: 1329–1334Google Scholar
  57. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS (2001) Global strategy for the diagnosis, management, and preventi¬on of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease ( GOLD) Workshop summary. Am J Respir Crit Care Med 163: 1256–1276Google Scholar
  58. Pryor JA (1999) Physiotherapy for airway clearance in adults. Eur Respir J 14: 1418–1424PubMedGoogle Scholar
  59. Rayner CFJ, Tillotson G, Cole PJ, Wilson R (1994) Efficiency and safety of long-term ciprofloxacin in the management of severe bronchiectasis. J Antimicrob Chemother 34: 149–156PubMedGoogle Scholar
  60. Reid LM (1950) Reduction in bronchial subdivision in bron¬chiectasis. Thorax 5: 233–247PubMedGoogle Scholar
  61. Simonds AK, Elliott MW (1995) Outcome of domiciliary nasal intermittent positive pressure ventilation in restrictive and obstructive disorders. Thorax 50: 604–609PubMedGoogle Scholar
  62. Sin DD, Tu JV (2001) Inhaled corticosteroids and the risk of mor¬tality and readmission in elderly patients with chronic ob¬structive pulmonary disease. Am J Respir Crit Care Med 164:Google Scholar
  63. Tsang KW, Ho PI, Chan KN et al. (1999) A pilot study of low-dose erythromycin in bronchiectasis. Eur Respir J 13: 361–364PubMedGoogle Scholar
  64. Tsang KWT, Chan WM, Ho PL, Chan K, Lam WK, Ip MSM (1999) A comparative study on the efficiency of levofloxacin and ceftazidime in acute exacerbation of bronchiectasis. Eur Respir J 14: 1206–1209PubMedGoogle Scholar
  65. Vincken W, van Noord JA, Greefhorst AP, Bantje TA, Kesten S, Korducki L, Cornelissen PJ (2002) Improved health outcomes in patients with COPD during 1 yr’s treatment with tiotropium. Eur Respir J 19: 209–216PubMedGoogle Scholar
  66. American Society for Transplant Physicians (ASTP), American Thoracic Society (ATS), European Respiratory Society (ERS), International Society for Heart and Lung Transplantation. (ISHLT) (1998) International guidelines for the selection of lung transplant candidates. Am J Respir Crit Care Med 58: 335–339Google Scholar
  67. American Thoracic Society (2000) Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. Am J Respir Crit Care Med 161: 646–664Google Scholar
  68. Anaya J-M, Diethelm L, Ortiz LA, Gutierrez M, Citera G, Welsh RA, Espinoza LR (1995) Pulmonary involvement in rheuma¬toid arthritis. Semin Arthritis Rheum 24: 242–254PubMedGoogle Scholar
  69. British Thoracic Society (1999) The diagnosis, assessment and treatment of diffuse parenchymal lung disease in adults. Tho¬rax 54: 1–30Google Scholar
  70. Cordier JF (2000) Pulmonary vasculitis. Eur Respir Mon 5: 226–243Google Scholar
  71. Costabel U, Guzman J (2000) Alveolar proteinosis. Eur Respir Mon 5: 194–205Google Scholar
  72. Deutsche Gesellschaft für Pneumologie (1994) Empfehlungen zum diagnostischen Vorgehen bei diffusen Lungenkrankhei¬ten. Pneumologie 48: 281–286Google Scholar
  73. Deutsche Gesellschaft für Pneumologie (1994) Empfehlungen zur diagnostischen bronchoalveolären Lavage. Pneumologie 48: 311–323Google Scholar
  74. Jennette JC, Falk RJ, Andrassy K et al. (1994) Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 37: 187–192Google Scholar
  75. Katzenstein A-LA, Myers JL (1998) Idiopathic pulmonary fibro¬sis. Clinical relevance of pathological classification. Am J Re¬spir Crit Care Med 157: 1301–1315Google Scholar
  76. Sullivan EJ (1998) Lymphangioleiomyomatosis. A review. Chest 114: 1689–1703PubMedGoogle Scholar
  77. Tazi A, Soler P, Hance AJ (2000) Pulmonary Langerhans’ cell his¬tiocytosis. Eur Respir Mon 5: 181–193Google Scholar
  78. Wells AU (2000) Lung disease in association with connective tis¬sue diseases. Eur Respir Mon 5: 137–164Google Scholar
  79. Crispin AR, Norman AP (1984) The systematic evaluation of the chest radio-graph in cystic fibrosis. Pediatr Radiol 2: 101–106 Cystic fibrosis Conference Reports (1978) CF patient evaluations and scoring systems. Tucson, AZ 2 (2)Google Scholar
  80. Gibson LE, Cooke RE (1959) A test for concentration of electro¬lytes in sweat in cystic fibrosis of the pancreas utilizing pilo¬carpine by iontophoresis. Pediatrics 23: 545–549PubMedGoogle Scholar
  81. Hoiby N (1993) Antibiotic therapy for chronic infection of Pseu¬domonas in the lung. Annu Rev Med 44: 1–10PubMedGoogle Scholar
  82. Kraemer R, Rüdeberg A, Kläy M, Rossi E (1979) Relationship between clinical conditions, radiographic findings and pul¬monary functions in patients with cystic fibrosis. Heiv Paedi¬at Acta 34: 417–428Google Scholar
  83. Shwachman H, Kulczycki LL (1958) A report of one hundred and one patients with cystic fibrosis of the pancreas studied over a five to fourteen year period. Am J Dis Child 96: 6–15Google Scholar
  84. Steinkamp G (1991) Antibiotikainhalation bei zystischer Fibrose. Monatschr Kinderheilkd 139: 73–80Google Scholar
  85. Stern RC (1997) The diagnosis of cystic fibrosis. New Engl J Med 336 (7): 487–491PubMedGoogle Scholar
  86. Szaff M, Hoiby N, Flensburg EW (1983) Frequent antibiotic the¬rapy improves survival of cystic fibrosis patients with chronic pseudomonas aeruginosa infection. Acta Paediatr Scand 72: 651PubMedGoogle Scholar
  87. Wood RE, Boat TF, Doershuk CF (1976) State of the art: cystic fibrosis. Am Rev Respir Dis 113: 833PubMedGoogle Scholar
  88. Deutsche Gesellschaft für Pneumologie (1998) Empfehlungen zur Diagnostik und Therapie der Sarkoidose. Pneumologie 52: 26–30Google Scholar
  89. Gibson G, Prescott R, Muers M et al. (1996) British Thoracic So¬ciety sarcoidosis study: Effects of long term corticosteroid treatment. Thorax 51: 238–247Google Scholar
  90. Hunninghake GW, Gilbert S, Pueringer R et al. (1994) Outcome of the treatment of sarcoidosis. Am J Respir Crit Care Med 149: 893–898PubMedGoogle Scholar
  91. Müller-Quernheim J (1992) Sarkoidose. In: Krück E, Kaufmann W, Bunte H, Gladtke E, Tölle R (Hrsg) Therapie - Handbuch. Urban and Schwarzenberg, MünchenGoogle Scholar
  92. Müller-Quernheim J, Dalhoff K, Schnabel A (1997) Immunsup¬pressive Therapie bei interstitiellen Lungenerkrankungen und immunologisch vermittelten Pneumonitiden. Internist (Berl) 38 (6): 553–561Google Scholar
  93. Müller-Quernheim J, Kienast K, Held M, Pfeifer S, Costabel U (1998) Treatment of sarcoidosis with an azathioprine/predni¬solone regimen. Eur Respir J 157: A31Google Scholar
  94. Müller-Quernheim J (1998) Sarcoidosis: immunopathogenetic concepts and their clinical application. Eur Respir J 12 (3): 716–738PubMedGoogle Scholar
  95. Shammas RL, Movahed A (1993) Sarcoidosis of the heart. Clin Cardiol 16: 462–472PubMedGoogle Scholar
  96. Viskum K, Vestbo J (1993) Vital prognosis in intrathoracic sar¬coidosis with special reference to pulmonary function and ra¬diological stage. Eur Respir J 6: 349–353PubMedGoogle Scholar
  97. Davis B, Systrom DM (1998) Lung abscess: Pathogenesis, diagnosis and treatment. Curr Clin Top Infect Dis 18: 252–273Google Scholar
  98. Ewig S, Schäfer H (2001) Lungenabszesse neu betrachtet. Pneumologie 55: 195–201PubMedGoogle Scholar
  99. Ewig S, Schäfer H (2001) Therapie der ambulant erworbenen aspirationsassoziierten Lungenabszesse. Pneumologie 55: 431–437PubMedGoogle Scholar
  100. Kemper P, Köhler D (1999) Stellenwert der intrapleuralen Fibri¬nolyse bei der Therapie exsudativer fibrinöser gekammerter Pleuraergüsse, beim Pleuraempyem und Hämatothorax. Pneumologie 53: 373–384PubMedGoogle Scholar
  101. Marik PE (2001) Aspiration pneumonitis and aspiration pneumo¬nia. N Eng J Med 344: 665–671Google Scholar
  102. Schaberg T, Ewig S (2001) Pneumonien. Thieme, Stuttgart New YorkGoogle Scholar
  103. Schülin T, Schaberg T, Lode H (1996) Diagnostik von Lungenabs¬zessen. Dtsch Med Wschr 121: 135–136PubMedGoogle Scholar
  104. Schülin T, Schaberg T, Lode H (1996) Therapie von Lungenabs¬zessen. Dtsch Med Wschr 121: 137–138PubMedGoogle Scholar
  105. Ewig S, Dalhoff K, Lorenz J, Mauch H, Schaberg T, Ukena D, Wel¬te T, Wilkens H, Witt Ch (1999) Deutsche Gesellschaft für Pneumologie - Empfehlungen zur Diagnostik Ewig S, Dalhoff K, Lorenz J, Schaberg T, Welte T, Wilkens H (2000) Nosokomiale Pneumonie: Empfehlungen zur Therapie und Prophylaxe. Pneumologie 54: 525–538Google Scholar
  106. Hospital-acquired pneumonia in adults (1995) Diagnosis, assess¬ment of severity, initial antimicrobial therapy, and preventati¬ve strategies. A consensus statement. Am J Respir Crit Care Med 153: 1711–1725Google Scholar
  107. Bartlett JG, Dowell SF, Mandell LA, File TM, Musher DM, Fine MJ (2000) Practical guidelines for the management of communi¬ty-acquired pneumonia in adults. Clinical Infectious Diseases 31: 347–382PubMedGoogle Scholar
  108. British Thoracic Society (2001) Guidelines for the management of community acquired pneumonia in adults. Thorax 56 Suppl 4Google Scholar
  109. Canadian Guidelines for the initial management of community-acquired pneumonia (2000) An evidence-based update by the Canadian Infectious Diseases Society and the Canadian Tho¬racic Society. Clin Infect Dis 31: 383–421Google Scholar
  110. Guidelines for the management of adults with community-acqui¬red pneumonia (2001) Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 163: 1730–1754Google Scholar
  111. Schaberg T, Dalhoff K, Ewig S, Lorenz J, Wilkens H (1998) Deut¬sche Gesellschaft für Pneumologie–Empfehlungen zur The¬rapie der ambulant erworbenen Pneumonie. Pneumologie 52: 450–462PubMedGoogle Scholar
  112. Aguilar D, Goldhaber SZ (1999) Clinical uses of low-molecular¬weight heparins. Chest 115: 1418–1423PubMedGoogle Scholar
  113. Decousus H, Leizorovicz A, Parent F et al. (1998) A clinical trial of vena cava filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. N Engl J Med 338: 409–415PubMedGoogle Scholar
  114. Elliott CG, Goldhaber SZ, Visani L, DeRosa M (2000) Chest ra¬diographs in acute pulmonary embolism. Results from the In¬ternational Cooperative Pulmonary Embolism Registry. Chest 118: 33–38Google Scholar
  115. Goldhaber SZ (1995) Contemporary pulmonary embolism thrombolysis. Chest 107: 455–51SGoogle Scholar
  116. Goldhaber SZ, Visani L, DeRosa M (1999) Acute pulmonary em¬bolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry ( ICOPER ). Lancet 353: 1386–1389Google Scholar
  117. Grosser KD (1988) Akute Lungenembolie. Behandlung nach Schweregraden. Dtsch Ärzteblatt 85: B587–594Google Scholar
  118. Kasper W, Konstantinides S, Geibel A et al. (1997) Management strategies and determinants of outcome in acute major pul¬monary embolism: results of a multicenter registry. J Am Coll Cardiol 30: 1165–1171PubMedGoogle Scholar
  119. Perrier A, Desmarais S, Miron MJ et al. (1999) Non-invasive di¬agnosis of venous thromboembolism in outpatients. Lancet 353: 190–195PubMedGoogle Scholar
  120. Stein PD, Coleman RE, Gottschalk A, Saltzman HA, Terrin ML, Weg JG (1991) Clinical, laboratory, roentgenographic and electrographic findings in patients with acute pulmonary em¬bolism and no pre-existing cardiac or pulmonary disease. Chest 100: 598–603PubMedGoogle Scholar
  121. The PIOPED investigators (1990) Value of the ventilation/perfusi¬on scan in acute pulmonary embolism. JAMA 263: 2753–2759Google Scholar
  122. Burke CM, Safai C, Nelson DP, Raffin TA (1986) Pulmonary arte¬riovenous malformations: a critical update. Am Rev Respir Dis 134 (2): 334–339PubMedGoogle Scholar
  123. Dines DE, Arms RA, Bernatz PE, Gomes MR (1974) Pulmonary arteriovenous fistulas. Mayo Clin Proc 49 (7): 460–465PubMedGoogle Scholar
  124. Gomes MR, Bernatz PE, Dines DE (1969) Pulmonary arteriove nous fistulas. Ann Thorac Surg 7 (6): 582–593PubMedGoogle Scholar
  125. Kiely B, Filler J, Stone S et al. (1967) Syndrome of anomalous venous drainage of the right lung to the inferior vena cava. A review of 67 reported cases and three new cases in children. Am J Cardiol 20: 102Google Scholar
  126. Kissner DG, Sorkin RP (1986) Anomalous pulmonary venous connection. Medical therapy. Chest 89 (5): 752–754PubMedGoogle Scholar
  127. Mortensson W, Lundström NR (1974) Congenital obstruction of the pulmonary veins at their atrial junctions. Review of the literature and a case report. Am Heart J 87: 359Google Scholar
  128. Amato MBP, Barbas CSV, Medeiros DM et al. (1998) Effect of a protective ventilation strategy on mortality in the acute respi¬ratory distress syndrome. N Engl J Med 338: 347–354PubMedGoogle Scholar
  129. Bernard GR, Artigas A, Brigham KL et al. and the Consensus Committee (1994) The American-European Consensus confe¬rence on ARDS. Am J Respir Crit Care Med 149: 818–824Google Scholar
  130. Gattinoni L, Tognoni G, Pesenti A et al. (2001) Supine study group effect of prone positioning on the survival of patients with acute respiratory failure. N Engl J Med 345: 568–573PubMedGoogle Scholar
  131. The Acute Respiratory Distress Syndrome Network (2000) Venti¬lation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 342: 1301–1308Google Scholar
  132. American Thoracic Society/European Respiratory Society (1997) Pretreatment evaluation of non-small-cell lung cancer. Am J Respir Crit Care Med 156: 320–332Google Scholar
  133. Bolliger C, Perruchoud A (1998) Functional evaluation of the lung resection candidate. Eur Respir J 11: 198–212PubMedGoogle Scholar
  134. Clinical Practice guidelines for the treatment of unresectable non-small-cell lung cancer (1997) J Clin Oncol 150: 2996–3018Google Scholar
  135. Deutsche Gesellschaft für Pneumologie (1998) Empfehlungen zur bronchoskopischen Behandlung tracheobronchialer Verschlösse, Stenosen und muraler maligner Tumoren. Pneumo¬logie 52: 243–248Google Scholar
  136. Deutsche Gesellschaft für Pneumologie (2000) Empfehlungen zur Diagnostik des Bronchialkarzinoms. Pneumologie 54: 361–371Google Scholar
  137. Deutsche Gesellschaft für Pneumologie (2002) Empfehlungen zur Therapie des Bronchialkarzinoms. Pneumologie 56: 113–131Google Scholar
  138. Pass H, Mitchell J, Johnson D, Turrisi A (eds) (2000) Lung Cancer Principles and Practice. Lippincott-Raven, Philadelphia Castleberry RP, Berthold F (1997) Neuroblastoma. Eur J Cancer 33: 1430–1438Google Scholar
  139. Koga K, Matsuno Y, Noguchi M, Mukai K, Asamura H, Goya T, Shimosato YA (1994) Review of 79 thymomas: modification of staging system and reappraisal of conventional division into invasive and non-invasive thymoma. Pathol Int 44: 359–367PubMedGoogle Scholar
  140. Lara PN Jr (2000) Malignant thymoma: current status and future directions. Cancer Treatm Rev 26: 127–131Google Scholar
  141. Latz D, Schraube P, Oppitz U, Kugler C, Manegold C, Flentje M, Wannenmacher MF (1997) Invasive thymoma: treatment with postoperative radiation therapy. Radiology 204: 859–864PubMedGoogle Scholar
  142. Levine GD, Rosai J (1978) Thymic hyperplasia and neoplasia: a review of current concepts. Hum Pathol 9: 495–515PubMedGoogle Scholar
  143. Masaoka A, Monden Y, Nakahara K, Tanioka T (1981) Follow-up study of thymomas with special reference to their clinical sta¬ges. Cancer 48: 2485–2492PubMedGoogle Scholar
  144. Schmoll H-J, Schneider P, Wildfang I, Wolf H-H (1999) Thymom. In: Schmoll H-J, Höffken K, Possinger K (Hrsg) Kompendium internistische Onkologie, vol 2. Springer, Berlin Heidelberg New York Tokyo, S 834–863Google Scholar
  145. Antony VB, Loddenkemper R, Astoul P, Boutin C, Goldstraw P, Hott J, Rodriguez-Panadero F, Sahn SA (2001) Management of malignant pleural effusions. Eur Respir J 18: 402–419PubMedGoogle Scholar
  146. Astoul P (1999) Pleural mesothelioma. Curr Opin Med 5: 259–268Google Scholar
  147. Boutard C, Gamondes JP, Mornex JF, Brune J (1998) La place du shunt pleuro-peritoneal de Denver dans le traitement des pleuresies chroniques. Ann Chir 52: 192–196Google Scholar
  148. Kirschner PA (1998) Porous diaphragm syndromes. Chest Surg Clin N Am 8: 449–472PubMedGoogle Scholar
  149. Kroegel C, Antony VB (1997) Immunobiology of pleural inflam¬mation: potential implications for pathogenesis, diagnosis and therapy. Eur Respir J 10: 2411–2418PubMedGoogle Scholar
  150. Light RW (1997) Diagnostic principles in pleural disease. Eur Re¬spir J 10: 476–482Google Scholar
  151. Loddenkemper R, Schönfeld N (1998) Medical thoracoscopy. Curr Opin Pulm Med 4: 235–238PubMedGoogle Scholar
  152. Massard G, Thomas P, Wihlm JM (1998) Minimally invasive ma¬nagement for first and recurrent pneumothorax. Ann Thorac Surg 66: 592–599PubMedGoogle Scholar
  153. Morelock SY, Sahn SA (1999) Drugs and pleura. Chest 116: 212–221PubMedGoogle Scholar
  154. Rodriguez-Panadero F, Antony VB (1997) Pleurodesis: state of the art. Eur Respir J 10: 1648–1654PubMedGoogle Scholar
  155. Rühle KH (1997) Pleura-Erkrankungen. Kohlhammer, Stuttgart Berlin KölnGoogle Scholar
  156. Schmidt M, Schaarschmidt G, Chemaissani A (1997) Pleurodese bei malignem Pleuraerguss: Bleomycin vs. Mitoxantron. Pneumologie 51: 367–372Google Scholar
  157. Sunder-Plasman L (1998) Das Pleuraempyem. Chirurg 69: 821–827Google Scholar
  158. American Sleep Disorders Association (ASDA) (1997) ICSD - The International Classification of Sleep Disorders, revised. Diagnostic and coding manual. American Sleep Disorders As¬sociationGoogle Scholar
  159. Ballester E et al. (1999) Evidence of the effectiveness of continu¬ous positive airway pressure in the treatment of sleepapnea/ hypopnea syndrome, Am J Respir Crit Care Med 159: 495–501PubMedGoogle Scholar
  160. Chesson AL Jr, Ferber RA, Fry JM et al. (1997) The indications for polysomnography and related procedures, part 1 of 7: Sleep-related breathing disorders (Sleep apnea and uppers air¬way resistance syndrome), part 2 of 7: other respiratory dis¬orders. Sleep 20: 424–450Google Scholar
  161. Deutsche Gesellschaft für Schlafforschung and Schlafmedizin (DGSM) (2001) Leitlinie Nicht Erholsamer Schlaf. Somnologie 5 (Suppl 1)Google Scholar
  162. Engelmann HM et al. (1999) Randomized placebo controlled crossover trial of continuous positive airway pressure for nightsleepapnea/hypopnea syndrome, Am J Respir Crit Care Med 159: 461–467Google Scholar
  163. Grote et al. (1999) Sleep related breathing disorder is an indepen¬dent risk-factor for systemic hypertension, Am J Respir Crit Care Med 160: 1875–1882PubMedGoogle Scholar
  164. Jenkinson C et al. (1999) Comparison of therapeutic and subthe¬rapeutic nasal continuous positive airway pressure for obst¬uctive sleepapnea: A randomized prospective parallel trial. Lancet 353: 2100–2105PubMedGoogle Scholar
  165. Peppard PE et al. (2000) Prospective study of the association bet¬ween sleep-disordered breathing and hypertension. N Eng1J Med 342: 1378–1384Google Scholar
  166. Téran-Santos J et al. (1999) The association between sleep-apnea and the risk of traffic accidents. N Engl J Med 340: 847–851PubMedGoogle Scholar
  167. Young T (1993) The occurrence of sleep disordered breathing among middle-aged adults. N Engl J Med 328: 1230–1235PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2003

Authors and Affiliations

  • Werner Seeger
  • Joachim Lorenz
  • J. Christian Virchow
  • Adrian Gillissen
  • Stefan Zielen
  • Tobias Welte
  • Claus Vogelmeier
  • Thomas O. F. Wagner
  • Joachim Müller-Quernheim
  • Bettina Temmesfeld-Wollbrück
  • Norbert Suttorp
  • Hans-Dieter Walmrath
  • Friedrich Grimminger
  • H. Ardeschir Ghofrani
  • Frank Rose
  • Friedrich Grimminger
  • Dietmar Schranz
  • Michael Thomas
  • Rudolf M. Huber
  • Hubert Wirtz
  • Michael Schmidt
  • Jörg Hermann Peter
  • Dennis Nowak

There are no affiliations available

Personalised recommendations